- Home
- BLMN vs BBNX Comparison
BLMN vs BBNX Comparison
Compare BLMN & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLMN
- BBNX
- Stock Information
- Founded
- BLMN 1988
- BBNX 2015
- Country
- BLMN United States
- BBNX United States
- Employees
- BLMN N/A
- BBNX N/A
- Industry
- BLMN Restaurants
- BBNX Medical/Dental Instruments
- Sector
- BLMN Consumer Discretionary
- BBNX Health Care
- Exchange
- BLMN Nasdaq
- BBNX Nasdaq
- Market Cap
- BLMN 714.5M
- BBNX 841.5M
- IPO Year
- BLMN 2012
- BBNX 2025
- Fundamental
- Price
- BLMN $9.51
- BBNX $17.89
- Analyst Decision
- BLMN Hold
- BBNX Strong Buy
- Analyst Count
- BLMN 11
- BBNX 10
- Target Price
- BLMN $13.25
- BBNX $25.20
- AVG Volume (30 Days)
- BLMN 2.4M
- BBNX 504.1K
- Earning Date
- BLMN 08-05-2025
- BBNX 08-06-2025
- Dividend Yield
- BLMN 6.33%
- BBNX N/A
- EPS Growth
- BLMN N/A
- BBNX N/A
- EPS
- BLMN N/A
- BBNX N/A
- Revenue
- BLMN $3,930,996,000.00
- BBNX $69,830,000.00
- Revenue This Year
- BLMN $1.28
- BBNX $32.79
- Revenue Next Year
- BLMN $1.55
- BBNX $36.59
- P/E Ratio
- BLMN $9.92
- BBNX N/A
- Revenue Growth
- BLMN N/A
- BBNX 38911.17
- 52 Week Low
- BLMN $6.09
- BBNX $8.89
- 52 Week High
- BLMN $21.45
- BBNX $24.50
- Technical
- Relative Strength Index (RSI)
- BLMN 62.16
- BBNX N/A
- Support Level
- BLMN $8.90
- BBNX N/A
- Resistance Level
- BLMN $9.65
- BBNX N/A
- Average True Range (ATR)
- BLMN 0.54
- BBNX 0.00
- MACD
- BLMN 0.17
- BBNX 0.00
- Stochastic Oscillator
- BLMN 93.99
- BBNX 0.00
About BLMN Bloomin' Brands Inc.
Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabbas. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S. while restaurants operating outside the U.S. are included in the international segment.
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.